Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Oncimmune Annual Loss Widens As Expenses Climb

30th Oct 2020 14:53

Oncimmune Holdings PLC - Nottingham-based immunodiagnostics company - Pretax loss in year ended May 31 stretches to USD9.8 million from USD8.5 million. Revenue rises to GBP509,000 from GBP171,000. Total administrative expenses up 21% to GBP9.4 million

Current stock price: 163.00 pence

Year-to-date change: up sharply from 38.50p

By Eric Cunha; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

Oncimmune
FTSE 100 Latest
Value8,809.74
Change53.53